Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis

被引：14
|
作者：
Beyer, Natascha Helena [1 ,2 ]
Lueking, Angelika [3 ]
Kowald, Axel [3 ]
Frederiksen, Jette Lautrup [4 ]
Heegaard, Niels H. H. [1 ]
机构：
[1] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen S, Denmark
[2] Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen S, Denmark
[3] Protagen AG, D-44227 Dortmund, Germany
[4] Glostrup Univ Hosp, Multiple Sclerosis Clin, Dept Neurol, DK-2600 Glostrup, Denmark
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 242卷 / 1-2期
关键词：
Autoantibody profiling; Biomarker; Cerebrospinal fluid; Multiple sclerosis; ANTIMYELIN BASIC-PROTEIN; OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES; MONOSYMPTOMATIC OPTIC NEURITIS; MYELIN-ASSOCIATED GLYCOPROTEIN; ALPHA-B-CRYSTALLIN; NEUROFILAMENT LIGHT; PROTEOLIPID PROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; ANTIGENIC CANDIDATES; SERUM AUTOANTIBODIES;
D O I：
10.1016/j.jneuroim.2011.08.013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Using the UNIarray (R) marker technology platform, cerebrospinal fluid immunoglobulin G reactivities of 15 controls and 17 RRMS patients against human recombinant proteins were investigated. Patient cerebrospinal fluids were oligoclonal band positive and reactivities were compared to that of sex- and age-matched controls. We hereby aimed at the characterization of autoreactivity in patients with RRMS. Differences in auto-reactivities between control and RRMS samples were identified comprising autoantigens identified in this study only and previously reported autoantigens as well. A combination of the 10-15 most significant proteins may be investigated further as autoantigens for diagnostic purposes. Additional investigations may include minimizing the number of proteins used in such diagnostic tests. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 50 条
  • [21] Altered erythrocyte MicroRNA profiles in relapsing-remitting multiple sclerosis
    Groen, K.
    Maltby, V. E.
    Tajouri, L.
    Lea, R. A.
    Fink, L.
    Sanders, K. A.
    Scott, R. J.
    Lechner-Scott, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 582 - 582
  • [22] Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity.
    Carrieri, PB
    Provitera, V
    De Rosa, T
    Tartaglia, G
    Gorga, F
    Perrella, O
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (03) : 373 - 382
  • [23] Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
    Martínez-Yélamos, A
    Saiz, A
    Bas, J
    Hernandez, JJ
    Graus, F
    Arbizu, T
    NEUROSCIENCE LETTERS, 2004, 363 (01) : 14 - 17
  • [24] Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    JOURNAL OF NEUROCHEMISTRY, 2017, 141 (02) : 296 - 304
  • [25] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47
  • [26] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [27] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [28] Comorbidity in in patients with relapsing-remitting multiple sclerosis.
    Somilo, O., V
    Makarov, S. O.
    Kalbus, O., I
    MEDICNI PERSPEKTIVI, 2024, 29 (03): : 137 - 143
  • [29] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
  • [30] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
12345